Monalisa Reis Arruda

Monalisa Reis Arruda

Auto-generated profile, based on publicly available information

Monalisa Reis Arruda

Graduate Program in Food, Nutrition, and Health, School of Nutrition Federal University of Bahia Salvador Bahia Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2026 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Open access
RJRosangela Passos de Jesus
Rosangela Passos de Jesus
LOLucivalda Pereira Magalhães de Oliveira
Lucivalda Pereira Magalhães de Oliveira
CCCarla de Magalhães Cunha
Carla de Magalhães Cunha
RBRamona Souza da Silva Baqueiro Boulhosa
Ramona Souza da Silva Baqueiro Boulhosa
ARAna Carolina Braga Porto Ricci
Ana Carolina Braga Porto Ricci
ABAllain A Bueno
Allain A Bueno
Background: Malnutrition is a common complication in patients with chronic diseases, often exacerbated by clinical factors and increased metabolic demands. In individuals affected by Decompensated Chronic Liver Disease (DCLD), fluid retention, such as oedema and ascites, can hinder accurate nutritional assessment, leading to underdiagnosis or misdiagnosis of weight loss and malnutrition. The present study describes the development and validation of a novel tool for Systematic Nutritional Clinical Assessment (SyNCA), including its content, semantic, and construct validity. Methods: In Phase 1, the Delphi protocol was employed to evaluate SyNCA content and semantic validity with input from clinical nutrition experts and resident nutritionists. Phase 2 involved a cross‐sectional, multicentre study of DCLD hospitalised patients to assess construct validity. SyNCA outcomes were compared with established nutritional assessment methods including anthropometry, handgrip strength (HGS), and dual‐energy X‐ray absorptiometry (DEXA). Correlations were analysed using Pearson or Spearman coefficients. Results: Following expert review in Phase 1, out of the 18 items initially proposed across five anatomical regions, 14 items were retained in the final SyNCA instrument. In Phase 2, data from 136 hospitalised DCLD patients revealed moderate correlations between SyNCA scores and arm muscle circumference ( r = −0.567, p < 0.0001), HGS ( r = −0.376, p < 0.0001), and Appendicular Muscle Mass Index ( r = −0.502, p < 0.001), supporting construct validity. Conclusion: SyNCA demonstrated strong content, semantic, and construct validity, demonstrating its potential as a reliable clinical tool for nutritional assessment in DCLD hospitalised patients, and particularly welcomed in clinical settings with limited resources or where traditional methods are impractical.

17 March 2026 in Nutrition
Verified
Journal Article
Open access
MAMonalisa Reis Arruda
Monalisa Reis Arruda
CCCarla de Magalhães Cunha
Carla de Magalhães Cunha
ABAna Clara Vital Batista
Ana Clara Vital Batista
RBRamona Souza da Silva Baqueiro Boulhosa
Ramona Souza da Silva Baqueiro Boulhosa
LGLaís Spíndola Garcêz
Laís Spíndola Garcêz
LOLucivalda Pereira Magalhães de Oliveira
Lucivalda Pereira Magalhães de Oliveira
Validated instruments specifically designed to assess the nutritional status of individuals with chronic liver disease (CLD) are scarce. The purpose of this study was to evaluate the psychometric properties of the Specific Nutrition Evaluation for Advanced Chronic Liver Disease (SNE-ACLD) instrument and establish cut-off points for the nutritional assessment of individuals with CLD. Hospitalized individuals with CLD were evaluated by SNE-ACLD and different nutritional assessment tools. Initial evidence of structural construct validity was assessed using principal component analysis; reliability using Cronbach's alpha; cut-off points were determined using cluster analysis. Criterion validity, in which the appendicular muscle mass index was adopted as a reference for concurrent validity using ROC curve; and Cox regression to assess the one-year mortality risk for predictive validity. Two hundred participants were evaluated, of which 75.0% were male, 50.5% were elderly, and 80.8% were classified as Child-Pugh B or C. Principal component analysis demonstrated that SNE-ACLD has four components that explain 69.9% of the total variance of the construct. Cronbach's alpha of 0.70 indicated a good interrelationship between the items. The established cut-off points classified the participants into four groups: without malnutrition, mild, moderate, or severe malnutrition. The SNE-ACLD showed concurrent validity with an AUC of 0.714 and predictive validity, with severely malnourished participants presenting one-year mortality risk almost five times higher (HR = 4.98; 95% CI: 2.42-10.2) than those without severe malnutrition. SNE-ACLD effectively addresses the domains of the malnutrition construct in this public, presenting evidence of both internal and external validity.

1 January 2026 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
ACAloma Conceição Magno Campeche-Leão
Aloma Conceição Magno Campeche-Leão
MAMonalisa Reis Arruda
Monalisa Reis Arruda
ABAna Clara Vital Batista
Ana Clara Vital Batista
LGLaís Garcêz
Laís Garcêz
RJRosangela Passos de Jesus
Rosangela Passos de Jesus
LCLourianne Nascimento Cavalcante
Lourianne Nascimento Cavalcante
Background: Sarcopenia is a highly prevalent and clinically impactful complication of cirrhosis, affecting 30-70% of patients depending on diagnostic criteria and disease stage. It is strongly associated with increased mortality, hepatic decompensation, infections, waitlist dropout, and inferior posttransplant outcomes. Despite growing recognition, the field remains limited by heterogeneous definitions, lack of standardized cutoffs, and inconsistent integration of functional and structural assessments. Objective and Methods: This narrative review synthesizes mechanistic pathways linking cirrhosis to muscle wasting, including hyperammonemia, anabolic resistance, systemic inflammation, hormonal dysregulation, and mitochondrial dysfunction, and critically evaluates current diagnostic tools such as CT morphometry, DEXA, BIA, and functional performance tests. Emerging biomarkers (myostatin, irisin, metabolomic signatures) and artificial intelligence-based imaging approaches are discussed as promising but still immature tools requiring validation. Conclusion: Therapeutic strategies remain constrained by low-quality evidence, with nutritional optimization, resistance training, and management of hepatic complications forming the cornerstone of care. Novel anabolic and anticatabolic therapies show potential but lack robust clinical trial data. Standardization of diagnostic criteria, integration of multimodal assessments, and development of targeted interventions represent urgent priorities to improve outcomes in cirrhosis-associated sarcopenia.

7 February 2026 in Nutrition
Verified
Journal Article
Closed access
DSDannieli Espirito Santo Silva
Dannieli Espirito Santo Silva
RBRamona Souza da Silva Baqueiro Boulhosa
Ramona Souza da Silva Baqueiro Boulhosa
MAMonalisa Reis Arruda
Monalisa Reis Arruda
ABAna Clara Vital Batista
Ana Clara Vital Batista
ALAndré Castro Lyra
André Castro Lyra
RJRosângela Passos de Jesus
Rosângela Passos de Jesus